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VP3optin in the replication of chicken anemia virus (CAV), an apoptin-knockout
clone, pCAV/Ap(−), was constructed. DNA replication was completely abolished in cells transfected with
replicative form of CAV/Ap(−). A reverse mutant competent in apoptin production regained the full level
of DNA replication. DNA replication and virus-like particle (VLP) production of CAV/Ap(−) was
fully complemented by supplementation of the wild-type apoptin. The virus yield of a point mutant,
CAV/ApT108I, was 1/40 that of the wild type, even though its DNA replication level was full. The infectious
titer of CAV was fully complemented by supplementing apoptin. Progeny virus was free from reverse
mutation for T108I. To localize the domain within apoptin molecule inevitable for CAV replication, apoptin-
mutant expressing plasmids, pAp1, pAp2, pAp3, and pAp4, were constructed by deleting amino acids 10–
36, 31–59, 59–88 and 80–112, respectively. While Ap1 and Ap2 were preferentially localized in nuclei, Ap3
and Ap4 were mainly present in cytoplasm. Although complementation capacity of Ap3 and Ap4 was 1/10
of the wild type, neither of them completely lost its activity. VP3 of TTV did fully complement the DNA
replication and VLP of CAV/Ap(−). These data suggest that apoptin is inevitable not only for DNA replication
but also VLP of CAV. The common feature of apoptin and TTV-VP3 presented another evidence for close
relatedness of CAV and TTV.
© 2008 Elsevier Inc. All rights reserved.Chicken anemia virus (CAV) was ﬁrst isolated in Japan (Yuasa et al.,
1979). CAV causes anemia by apoptosis of hemocytoblasts in bone
marrow (Taniguchi et al., 1983). Chicken thymocytes and lympho-
blastoid cells can also be infected with CAV and undergo apoptosis
(Jeurissen et al., 1992). The virus is immunosuppressive in newborn
chickens, and induces generalized lymphoid atrophy, severe anemia
and increased mortality (Adair, 2000).
CAV is a small non-enveloped virus with a single-stranded circular
DNA genome in the size of approximately 2.3 kb (Noteborn et al., 1991;
Todd et al., 1990). CAV is the only member of genus Gyrovirus within
family Circoviridae. CAV has open reading frames (ORFs) only on the
antigenomic strand, in contrast to the other members of circoviruses
that have ambisense genome (Bendinelli et al., 2001; Miyata et al.,
1999; Noteborn et al., 1991). The major structural protein (VP1) of
circoviruses is coded for by the genomic strand, while at least two
other proteins (VP2 and VP3) by the antigenomic strand.nda-Surugadai, Chiyoda, Tokyo
y of Medicine, Sebelas Maret
.
esearch Institute for Microbial
65-0871, Osaka, Japan.
l rights reserved.On the other hand, the arrangement of ORFs of CAV is quite similar
to that of torque teno virus (TTV) (Bendinelli et al., 2001; Hino and
Miyata, 2007; Miyata et al., 1999; Mushahwar et al., 1999). These two
viruses have a N80% similarity in a 36-nt stretch near the replication
origin, but nucleotide sequences of the remaining genome show no
apparent similarities (Hino and Miyata, 2007; Miyata et al., 1999).
Their transcription patterns to produce three or more spliced mRNAs
are also similar to each other (Kamada et al., 2006; Kamahora et al.,
2000; Qiu et al., 2005). TTV is currently classiﬁed into genus Anello-
virus in family Circoviridae (Bendinelli et al., 2001; Hino and Miyata,
2007; ICTVdB, 2006). However, because of enormous diversity of
TTVs, a new family Anelloviridaewill probably set up in the near future
(Anonymous, 2007). In contrast, arguments to relocate CAV outside
Circoviridae seem to be less extensive.
CAV replicates via a circular double-stranded replicative form (RF)
(Noteborn et al., 1991). The major transcript of CAV is an unspliced
polycistronic mRNA which possesses three overlapping ORFs encod-
ing VP1 (52 kDa), VP2 (24 kDa) and VP3 (14 kDa) (Claessens et al.,
1991; Noteborn et al., 1991). VP1 is the major viral capsid protein. VP2
is a non-structural protein with phosphatase activity of dual speci-
ﬁcities and has been shown to interact with VP1 (Noteborn et al., 1998;
Peters et al., 2002). Both VP1 and VP2 are indispensable for CAV
replication (Peters et al., 2006; Yamaguchi et al., 2001). VP3, also
named apoptin, is a non-structural protein made of 121 amino acids
Fig.1. Infectious CAV in the culture ﬂuid after transfection with RF DNA. Culture ﬂuids
of MDCC-MSB1 cells transfected with CAV/WT (○), CAV/Ap(−) (□), CAV/ApRM (●) or
CAV/ApT108I (▵) were tested for infectious CAV titer. Arrows indicate the titer less
than the detection limit of the assay (1.9 log10 [TCID50/culture]). Three independent
experiments gave essentially the same results.
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of CAV, their biological meanings have not been elucidated (Kamada
et al., 2006).
Apoptin has a number of proline, serine and threonine residues,
and positively charged at C-terminus (Noteborn, 2004). Apoptin
induces apoptosis selectively in transformed cells but not in non-
transformed cells (Maddika et al., 2006; Oorschot et al., 1997).
Maintenance of the apoptin gene in CAV implies the signiﬁcance of
apoptin in life cycle of CAV (Noteborn et al., 1994); however, no
direct evidences for the necessity of apoptin in CAV replication have
been ever given to the best of our knowledge. Interestingly, Kooistra
et al. (2004) reported the apoptotic activity of an ORF-3 protein
(105 aa) of TTV, with a limited similarity in their sequence to
apoptin. Because of similarity in the gene localization of this protein
and that of apoptin, starting at near 5′-terminus of VP1 and
residing on the frame 3 (Miyata et al., 1999), we call this protein as
TTV-VP3 in this report. The present study provided the ﬁrst
evidence of the necessity of apoptin in DNA replication and virus
particle production of CAV, and ability of TTV-VP3 to complement
apoptin.Fig. 2. Schematic diagram on genomic structure of CAV. An apoptin knockout clone, pCAV/A
amino acid change in the overlapping VP2. pCAV/ApT108I was obtained by a similar strategy
stream.Results
Infectious virus after transfection with RF DNA of CAV
Following transfectionwith RF DNA of the wild-type CAV, CAV/WT,
into transformed chicken MDCC-MSB1 cells, infectious viruses in the
culture ﬂuid were titrated at 24, 48 and 72 h. Infectious viruses were
ﬁrst detected at 48 h posttransfection in the titer of 3.8×103 TCID50/
culture, which increased signiﬁcantly at 72 h to the titer of 4.6×104
TCID50/culture (Fig. 1).
In order to test the requirement of apoptin in the replication of
CAV, pCAV/Ap(−) was constructed by disrupting the initiation codon of
apoptin in pCAV/WT (Fig. 2). No infectious viruses were detected at all
even at 72 h after transfection with RF DNA of CAV/Ap(−) (Fig. 1). A
reverse mutant with the reorganized apoptin gene obtained from
CAV/Ap(−), CAV/ApRM, regained full recovery in the infectious virus
production (Fig. 1). The data suggest that apoptin is indispensable for
infectious virus production of CAV.
Threonine108 of apoptin is phosphorylated speciﬁcally in tumor
cells (Rohn et al., 2002). Apoptin with a point mutation at T108A
essentially stays in the cytoplasmic compartment, and has a reduced
apoptotic activity (Poon et al., 2005a; Rohn et al., 2002). A point
mutant with a silent mutation in the second frame, pCAV/ApT108I, was
constructed (Fig. 2). Infectious virus titer at 72 h posttransfection by
transfection of CAV/ApT108I, 1.0×104 TCID50/culture, was 1/40 of that
by transfection of CAV/WT, 4.0×105 TCID50/culture (Fig.1, Table 1). The
data suggest that T108I mutation of apoptin signiﬁcantly reduces
infectious virus titer of CAV.
CAV DNA replication in cells
Replication of CAV DNA was surveyed at 72 h posttransfection
of CAV/WT RF DNA (Table 1). CAV DNA was detected at the level
of 1.6×108 copies/culture. However, DNA replication was undetect-
able by transfection with the equal amount of pCAV/WT, nor by
sham transfection in the absence of a transfection reagent, FuGENE
HD. The level of DNA replication was not affected with or without
co-transfection of the backbone vector plasmid used for apoptin
supplement, pHM6. Moreover, DNA replication after transfection
with RF DNA of CAV/Ap(−) was undetectable. This was fully res-
cued by supplementing apoptin, i.e. by co-transfection with pAp/
WT (Table 1). However, co-transfection of backbone pHM6 could
not. The level of DNA replication by transfection of CAV/ApRM
was the same as that of CAV/WT. Thus, the apoptin itself was
found inevitable for the DNA replication of CAV. Infectious virus
titer in the cellular extract was approximately 10 times higherp(−), was designed to point-mutate the initiation codon of apoptin without inducing an
. The region used for PCR detection of CAV DNA, nt 1585–1746, is located in the down
Fig. 3. Tagged apoptin and TTV-VP3 in expression vector, pHM6, and their subcellular
localization in COS-1 cells. (A) Schematic diagrams of the wild-type apoptin and its four
mutants, and of TTV-VP3. They were tagged with an HA-epitope at its N-terminus.
Positions deleted in Ap1 through Ap4 are shown. (B) Proportion of cells with the nuclear
staining (those with N50% signals in the nuclear region) after transfection with one of
the expression plasmids. At least 100 transfection-positive cells were counted. The
results are the average of three independent experiments.
Table 1
DNA replication and infectious virus of CAV within cells transfected with RF DNA of CAV
and its mutants at 72 h posttransfection
Transfection with Co-transfected
with
CAV DNA Virus titer
Copies/culture
(log10)
TCID50/culture
(log10)
RF DNA of
CAV/WT None 8.2 5.6
pHM6 8.2 5.6
CAV/Ap(−) None ND ND
pAp/WT 8.2 ND
pHM6 ND ND
CAV/ApRM None 8.2 5.6
CAV/ApT108I None 8.2 4.0
pAp/WT 8.2 5.6
pHM6 8.2 4.0
pCAV/WT (plasmid form) None ND ND
ND: not detectable.
CAV DNA and infectious virus were undetectable after transfection by RF DNA of CAV/
WT without transfection reagent, FuGENE HD. Minimum detection level of CAV DNA
was 6.2 log10 copies/culture and of infectious virus titer was 1.9 log10 TCID50/culture.
Three independent experiments gave essentially the same results.
87A.A. Prasetyo et al. / Virology 385 (2009) 85–92than that of extracellular ﬂuid up to 72 h posttransfection (Table 1
and Fig. 1).
Both extracellular and intracellular virus titers after transfection of
CAV/ApT108I were 1/40 of those after transfection of CAV/WT (Fig. 1
and Table 1). Nevertheless, DNA replication of CAV/ApT108I was in the
same level as that of CAV/WT (Table 1). The data suggest that the point
mutation affects the process on virus particle production than viral
DNA replication, and that the mechanism of apoptin action on CAV
replication consists of at least these two different steps.
Apoptin complements DNA replication of CAV/Ap(−) and CAV/ApT108I
To test if the CAV/Ap(−) replication could be complemented by
apoptin, RF DNA of CAV/Ap(−) was co-transfected with an apoptin
expressing plasmid, pApWT. As expected, infectious virus production
was not detected after this complementation (Table 1). However, the
DNA replication was fully complemented to the level of the wild type
by supplying competent apoptin. The backbone plasmid, pHM6, could
complement neither infectious virus production nor DNA replication
of CAV/Ap(−) (Table 1).
Moreover, the infectious virus titer of CAV/ApT108I (1.0×104 TCID50/
culture) was fully complementedwith thewild-type apoptin to that of
wild-type virus (4.0×105 TCID50/culture) (Table 1). Sequencing of the
resultant high titered virus revealed no reversed mutations at T108I
(data not shown). The CAV DNA level in cells co-transfected with CAV/
ApT108I RF DNA and pAp/WTwaswithin that of thewild type (Table 1).
Complementation of CAV/Ap(−) DNA replication by apoptin mutants
In the literature, a bipartite nuclear localization signal (NLS) is
responsible for apoptin nuclear translocation in tumor cells: NLS1 at
aa 84–90 (PSKKRSC) and NLS2 at aa 112–118 (PRTARRR) (Oorschot et
al., 2003). The disruption of these NLSs reduced nuclear transport and
apoptosis induction in tumor cells. Apoptin also possesses a leucine-
rich sequence (LRS) in its N-terminus (aa 33–44, IRIGIAGITITLSL),
which is considered as nuclear export signal or cytoplasmic retention
signal (CRS), because apoptinwithout LRS is essentially retained in the
nucleus (Poon et al., 2005b).
To ﬁnd out which regionwithin apoptinmolecule is responsible for
the CAV replication, plasmids expressing mutant apoptins, pAp1,
pAp2, pAp3, and pAp4, were constructed in which aa 10–36, 31–59,
59–88 and 80–112 of apoptin were deleted, respectively (Fig. 3A). Ap1
lacks just N-terminus three amino acids of LRS and Ap2 lacks whole
LRS, while Ap3 and Ap4 lack NLS1. In addition, pApT108I with T108I
mutation was also prepared.Expression of these mutated apoptin with HA tag was ﬁrst tested
in ﬂoating MDCC-MSB1 cells under ﬂuorescent microscopy. However,
their intracellular distributions could not be visualized because of
extremely low efﬁciency in transfection and of scanty cytoplasm in
ﬂoating MDCC-MSB1 cells (data not shown). In COS-1 cells, N60% of
cells expressing the wild-type apoptin showed a nuclear dominant
staining. Nuclear dominant staining was observed in N80% of cells
expressing Ap1 and Ap2, while in b30% of cells expressing Ap3 and
Ap4 (Fig. 3B). Nuclear dominant staining was observed in appro-
ximately 40% of cells expressing ApT108I, which value was closer
to those of Ap3 and Ap4 (Fig. 3B). Interestingly, the replication of
CAV/Ap(−) RF DNA was complemented fully with Ap1 and Ap2, and
to the level of 1/10 with Ap3 and Ap4 (Table 2). The mutant, ApT108I,
also showed full capability of complementation (Table 2). As
expected from the nature of complementation, none of these mu-
tants recovered the infectious CAV production from CAV/Ap(−) (data
not shown).
Fig. 5. CAV virus-like particle (VLP) production after complementation of CAV/Ap(−)
by co-transfection with pApWT or pTTV-VP3. (A) Titer of CAV/WT in each fraction
after a 30–60% sucrose density gradient centrifugation and density of each fraction.
(B) Co-migration of CAV DNA with the VLP fraction. VLPs in each fraction were
pelleted by ultracentrifugation and the resuspended pellet was treated with DNase.
Thereafter, DNA was extracted, treated with DpnI to digest out the input RF DNA, and
used as a template for CAVDNA titration by PCR. CAV/WT (○), CAV/Ap(−) complemented
with pApWT (▪) orwith pTTV-VP3 (●). Negative controls: CAV/Ap(−) (□) or RF CAV/WTonly (DNA without the transfection reagent, FuGENE HD) (▵).
Table 2
Complementation of CAV/Ap(−) DNA replication by apoptin and its mutants and by
TTV-VP3
Transfection CAV DNA
RF DNA With apoptin Copies/culture (log10)
CAV/Ap(−) None ND
ApWT 8.2
ApT108I 7.2
Ap1 8.2
Ap2 8.2
Ap3 7.2
Ap4 7.2
TTV-VP3 8.2
ND: not detectable.
See legend of Table 1.
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On the third frame of TA278 (GenBank AB008394), one of the
subgroup 1 TTVs, resides an open reading frame (ORF) for a 105-aa
protein (VP3) spanning nt 372–686 (Miyata et al., 1999). Kooistra et al.
(2004) reported that this protein had a higher apoptosis-inducing
activity in human hepatocellular carcinoma (HCC) cells than in non-
HCC cells, and named it TTV-derived apoptosis-inducing protein
(TAIP).
Complementation by TTV-VP3 on the replication of CAV/Ap(−)
was tested. MDCC-MSB1 cells were co-transfected with RF DNA of
CAV/Ap(−) and pTTV-VP3. Surprisingly, the replication of CAV/Ap(−)
was fully complemented by TTV-VP3 (Table 2). Intracellular localiza-
tion of TTV-VP3 was also tested by HA-tagged protein in COS-1 cells.
The level of cells with dominant nuclear staining with TTV-VP3 was
approximately 60% nearly equal to that of the wild-type apoptin (Fig.
3B), which is consistent with the full complementation capacity of
TTV-VP3 for CAV/Ap(−) DNA replication.
Southern blot analysis
Southern blots were performed to conﬁrm these PCR data, because
the background signal of input DNA could not be eliminated even after
DpnI restriction. In the Southern blot, the double- and single-stranded
DNA bands of CAV were observed after transfection of RF CAV/WT
DNA (Fig. 4, lane 1). However, no appreciable signals were detected by
mock transfections, either of CAV/WT DNA in the plasmid form (lane
12), or of RF CAV/WT DNA without the FuGENE HD transfection
reagent (lane 13). These data suggest that the signal on the Southern
blot reﬂects de novo synthesized CAV DNA.
In comparison to CAV/WT, CAV/ApT108I showed the same level of
single and double stranded DNAs with or without complementation
with ApWT (lanes 3 and 2, respectively). No replications of CAV DNAFig. 4. Southern blot of the MDCC-MSB1 DNA transfected with RF DNA of CAVs. Lanes, 1:
CAV/WT; 2: CAV/ApT108I; 3: CAV/ApT108I co-transfected with pApWT; 4: CAV/Ap(−); 5
through 11: CAV/Ap(−) co-transfected with pApWT, pAp1, pAp2, pAp3, pAp4, pApT108I
and pTTV-VP3, respectively; 12: pCAV/WT (as circular plasmid) with FuGENEHD; 13: RF
CAV/WT DNA without FuGENE HD. Bars on the left margin point to the CAV-DNA, ss:
ssDNA; ds: dsDNA.were detectable by the transfection of RF CAV/Ap(−) (lane 4), which
was fully complemented by ApWT (lane 5) and by TTV-VP3 (lane 11).
While CAV/Ap(−) was completely rescued by two deletion mutants at
the N-terminal region, Ap1 and Ap2, it was only partially rescued by
the other three deletion mutants at the C-terminal region, Ap3, Ap4
and ApT108I (lanes 6–10).
Virus-like particle production after complementation with apoptin and
TTV-VP3
Both CAV-apoptin and TTV-VP3 were found to complement the
replication of CAV/Ap(−) DNA. Next obvious question is if the
complementation by these proteins is associated with the virus-like
particle (VLP) production. VLP was partially puriﬁed by a sucrose
density centrifugation. The peak of infectious virus particle was
observed at the fraction 4 by titration of infectious viruses (Fig. 5A).
CAV DNA in the cell extract transfected with CAV/WT revealed that
the viral DNA was co-fractionated with the infectious virus particles
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DNA did co-migrate to the same fraction as VLP after complementation
with ApWT, and also with TTV-VP3, (Fig. 5B). Neither cells transfected
with RF DNA of CAV/Ap(−) alone, nor those sham transfected with RF
DNA of CAV/WT in the absence of the transfection reagent, FuGENE HD,
did not show VLP peak in the same fraction.
Discussion
Apoptin of CAV induces apoptosis in chicken thymocytes and
lymphoblastoid cells. Apoptosis of human cancer cells by apoptin has
been studied extensively (Maddika et al., 2006; Noteborn et al., 1994;
Oorschot et al., 1997); however, the requirement apoptin for CAV
replication has not been elucidated. This study provides the ﬁrst
direct evidence that apoptin is indispensable for CAV replication. Not
only virus particle production but also DNA replication was com-
pletely knocked out in CAV/Ap(−). The defect of CAV/Ap(−) was fully
recovered by the reverse mutation. The DNA replication of CAV/Ap(−)
is restored by substitution of apoptin, but the production of infec-
tious virus particles could not be rescued at all, indicating the me-
chanism of recovery in the DNA replication is complementation, not
recombination.
Threonine108 of apoptin is phosphorylated in transformed cells,
and the loss of hydroxyl group for phosphorylation on T108 signi-
ﬁcantly reduces its apoptotic function (Lee et al., 2007; Maddika et al.,
2007; Poon et al., 2005a; Rohn et al., 2002). Poon et al. (2005a)
claimed that this phosphorylation is directly associated with its
nuclear export using apoptin mutants. An apoptin lacking in aa 1–73
remained in cytoplasm, while an apoptin devoid of aa 74–121 stayed
in the nucleus. For the induction of apoptosis, nuclear localization is
required but not sufﬁcient (Zhang et al., 2004).
While the CAV DNA replication of CAV/ApT108I was as high as that
of the wild type, the infectious CAV/ApT108I production was 1/40 that
of CAV/WT. These data demonstrate that the T108I mutation does affect
the CAV virus particle production but not the DNA replication of CAV.
When cells were supplemented with the wild-type apoptin by co-
transfection of pAp/WT, the virus titer of infectious CAV/ApT108I
recovered to the level of the wild type without increasing the repli-
cation of viral DNA. Virus particles produced after the complementa-
tion retained the T108I mutation, suggesting that the increased virus
particle production is directly associatedwith the function of thewild-
type apoptin.
In these experiments, we could not specify the region within an
apoptin molecule indispensable for the CAV replication, because Ap1
and Ap2 had full complementation capacity as the wild-type apoptin.
However, the DNA replication levels of CAV/Ap(−) complemented by
Ap3, Ap4 and ApT108I were approximately 1/10 that of by the wild-
type virus. The results suggested that C-terminal region of apoptin
molecule is more responsible for the DNA replication of CAV.
The results of PCR and Southern blot experiments were consistent
each other. In the literature, apoptin deleted of 11 codons at its 3′-
terminus retained apoptotic ability (Oorschot et al., 1997; Zhuang
et al., 1995). Also, a truncated apoptin consisting of aa 1–59 was
sufﬁcient to bind Hippi, a protein interactor of Huntingtin-interacting
protein 1 (Cheng et al., 2003). On the other hand, another apoptin
mutant, truncated of the C-terminus and without the phosphoryla-
tion site, kept the nuclear translocation and the apoptotic capacity
(Guelen et al., 2004). The N-terminus (aa 1–69) and C-terminus (aa
80–121) domains of apoptin induce apoptosis independently,
although the apoptotic potency of these proteins were less than that
of the wild-type apoptin (Oorschot et al., 2003). These previously
reported data suggest that the functional domains of apoptin are not
restricted in a single region (Rohn et al., 2005). Theymay be consistent
with the current observation that none of four apoptin mutants
completely lost the complementation capacity for the DNA replication
of CAV/Ap(−).At present, the action mechanism of apoptin on VLP production
has not been elucidated. Association of nuclear localization found
between apoptin and VLP production in this study seems rational,
because both DNA replication and VLP formation of CAV should be
intranuclear processes considering that CAV is a small DNA virus. VP1
on the frame 1 has been suggested to act as the capsid protein, and
the VP2 on the frame 2 has been claimed to be scavenger protein for
the virus particle formation (Koch et al., 1995; Noteborn et al., 1998;
Todd et al., 1990). These proteins may be required by the virus for
replicative or transcriptional functions, since VP2 and VP3 are
produced very early in the infectious cycle (12 h postinfection) and
deposited in large amounts within the nucleus of infected cells
(Douglas et al., 1995). The data presented here clearly demonstrated
the requirement of apoptin in CAV DNA replication and its virus
particle formation. The functions of other putative proteins depen-
dent on the spliced mRNAs (Kamada et al., 2006) await further
studies.
CAV has a similarity to TTV in its genomic organization (Miyata
et al., 1999; Mushahwar et al., 1999). By splicing, not only TTV but also
CAV produces at least three different classes of mRNAs with the same
5′- and 3′-termini, using common TATA-box and polyA-site (Kamada
et al., 2006; Kamahora et al., 2000). The 36-nt stretches in the genome
of these two viruses have an N80% sequence similarity (Miyata et al.,
1999). Although the nucleotide sequence similarity of these viruses is
not observed in other parts of the genome (Miyata et al., 1999), the N-
termini of both CAV-VP1 and TTV-VP1 have a short amino acid motif
common for proteins associated with DNA replication by the rolling-
circle mechanism (Bendinelli et al., 2001). Both CAV-VP2 and TTV-VP2
are the protein phosphatase of dual speciﬁcities (Peters et al., 2002).
Furthermore, both viral DNA replication and virus particle formation
of apoptin-defective CAV/Ap(−) were complemented either by apoptin
itself or by TTV-VP3. Thus, all three major proteins of CAV and TTV
have common features, suggesting the close relation between these
two viruses. Lines of evidence provided by this report added further
evidence for the functional similarity in VP3 s of CAV and TTV.
However, even though Kooistra et al. (2004) pointed out the
similarity of these proteins by apoptotic activity, proline-rich nature
and hydrophobic amino acid stretch, similarity of their amino
sequences does not seem to be substantial. Although an N-
mylistoylation site was observed on CAV apoptin [located at aa 39–
44 (GITITL) and aa 48–53 (GCANAR)] and on TTV VP3 aa 57–62
(GCRLSR), it is not likely the key factor for this complementation,
because AP2 completely lacking this domain still showed the
signiﬁcant capacity of complementation. To date, no conformational
similarities in these proteins are available. Reason for the comparable
capacity for complementing CAV/Ap(−) DNA replication remains a
target in further studies. Complementation of apoptin deﬁciency by
TTV-VP3 cannot be common, because ORF of VP3 is not open in all TTV
genotypes. Furthermore, the expression of this ORF has not been
conﬁrmed in a full length TTV clone.
Materials and methods
Cell culture
Chicken T cells transformed by Marek's disease virus, MDCC-MSB1,
were used to replicate CAV (Akiyama and Kato, 1974). Cells were
subcultured twice weekly at 39 °C in RPMI1640 medium (Sigma,
Stenheim, Germany) supplemented with 10% fetal bovine serum (FBS,
Immuno-Biological Laboratories, Fujioka, Japan), 2 mM glutamine,
and 0.01% each of penicillin and streptomycin. African green monkey
kidney cell expressing SV40 T antigen, COS-1, was used to visualize
intracellular localization of apoptin and its mutants. Cells were
subcultured twice weekly at 37 °C in Dulbecco's modiﬁed Eagle
medium supplemented with 10% FBS, 2 mM glutamine and 0.01% each
of penicillin and streptomycin.
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A molecular clone of the wild-type CAV (CAV/WT), pCAV-A2C15
(pCAV/WT) (GenBank AB031296), was kindly supplied by Dr.
Yamaguchi, National Institute of Animal Health, Japan (Yamaguchi
et al., 2001). To construct a CAV clone knocked out of apoptin, an point
mutation, A465TG to ACG, was introduced to the initiation codon of
apoptin gene on the frame 3 (Fig. 2). The mutationwas designed to be
synonymous in VP2 on the frame 2. Brieﬂy, a reversed long PCR was
performed by QuickChange Site-directed Mutagenesis kit (Stratagene,
La Jolla, CA) using pCAV/WT as a template and a pair of primers,
mApM-s (5′-GCA AGT AAT TTC AAA CGA A465CG CTC TCC AAG-3′) and
mApM-as (5′-CTT GGAGAG CGT465 TCG TTT GAA ATTACT TGC-3′). The
PCR was performed for 16 cycles with denaturing at 94 °C for 1 min,
annealing at 55 °C for 1 min, and elongation at 72 °C for 11min in each
cycle. The mutant plasmid was named as pCAV/Ap(−). A reverse
mutant, pCAV/ApRM, was prepared by a similar long PCR using
pCAV/Ap(−) as a template and a pair of primers ApRM-s (5′-GCA AGT
AAT TTC AAA CGA A465TG CTC TCC AAG-3′) and ApRM-as (5′-CTT GGA
GAG CAT465 TCG TTT GAA ATT ACT TGC-3′).
Poor performance of apoptin with a point mutation of threo-
nine108 to isoleucine has been reported (Rohn et al., 2002). pCAV/
ApT108I was constructed by the similar reversed long PCR using two
primers, mApT108-s (5′-GC TTG ATT ACC ACT A786TT CCC AGC CG-3′)
and mApT108-as (5′-CG GCT GGG AAT786 AGT GGT AAT CAA GC-3′).
This point mutation was selected to induce a silent mutation in the
ORF2 of CAV/WT (Fig. 2). The PCR condition was the same as above.
All molecular clones in this report were sequenced by dideoxy-
sequencing method (Sanger et al., 1977) with a SequiTherm Excel II
sequencing kit (Epicentre Biotechnologies, Madison, WS). The
nucleotide sequence was analyzed by Genetyx version 7.0 (Genetyx,
Tokyo, Japan).
Tagged apoptin and its mutants in an expression vector (pHM6)
Molecular clones to complement apoptin-defective CAV, CAV/Ap(−),
were constructed. A complete open reading frame of the apoptin
gene of CAV/WT was ampliﬁed by PCR using primers 475-s (5′-CGG
GTA CCA468 ACG CTC TCC AAG AAG ATA CT488-3′) and 830-as (5′-CCG
AAT TCT830 TAC AGT CTT ATA CAC CTT CT810-3′). For cloning, each
primer was attached with a KpnI or EcoRI recognition site (indicated
in italics). The PCR conditionwas the same as above. The PCR product
digested with KpnI/EcoRI was subcloned into the respective sites
of pHM6 vector (Roche Diagnostics, Mannheim, Germany). The clone
thus obtained, pApWT, expressed a wild-type apoptin tagged with
HA-epitope at its N-terminus. Using this clone as a template,
pApT108I was constructed using same primers and PCR condition as
in pCAV/ApT108I construction.
To obtain deletion mutants of apoptin, Ap1, Ap2, Ap3 and Ap4,
molecular clones, pAp1, pAp2, pAp3, and pAp4, were constructed (Fig.
3A). Brieﬂy, pAp1 was constructed as follows. Restriction of pApWT
(5796 bp) with HindIII gave 5481 bp and 315 bp fragments. The longer
arm piece was dephosphorylated with calf intestinal alkaline phos-
phatase (New England BioLabs, Ipswich, MA) and was puriﬁed using
QIAquick nucleotide removal kit (Qiagen, Hilden, Germany). The
shorter piece was self-ligated using T4 DNA ligase (Promega, Madison,
Wisconsin) and served in a reverse PCR with phosphorylated primers,
ApM1L (5′-G971GT GGA GTA TCT TCT TGG AGA GCG948-3′) and ApM1U
(5′-C1053GC TGG AAT TAC AAT CAC TCT ATC G1077-3′). The product was
puriﬁed by electrophoresis in a 3% agarose S gel (Takara, Kyoto, Japan),
recovered with the gel extraction kit (Qiagen), circularized by liga-
tion, digested with HindIII, and then ligated back into the longer
arm piece using T4 DNA ligase (Promega). Similar strategies were used
to obtain pAp2, utilizing ApM2L (5′-C1034TG CAG TGA GGG GTT TTC
CAA C1014-3′) and ApM2U (5′-T1125GC GGA CAA TTC AGA AAG CAC
TGG1148-3′) primers.To obtain pAp3, pApWT was digested with PstI into 4138 bp and
1658 bp fragments. The longer arm piece was dephosphorylated and
puriﬁed. The shorter piece was recircularized and served for a
reverse PCR with phosphorylated primers, ApM3L (5′-G1118AT CTT
AGC GTG GGA GCG CGA1098-3′) and ApM3U (5′-C1209TG CGA CCC CTC
CGA GTA CA1228-3′). PCR product was puriﬁed, circularized, digested
with PstI, and then ligated back into the arm piece. To obtain pAp4, a
pair of phosphorylated primers, ApM4L (5′-T1186GG GTT GAT CGG
TCC TCA A1168-3′) and ApM4U (5′-C1283CG CAA GAA GGT GTA TAA
GAC TG1305-3′), were used. The reversed PCRs were performed for
30 cycles with denaturing at 94 °C for 1 min, annealing at 53 °C
(ApM1U/ApM1L), 53 °C (ApM2U/ApM2L), 57 °C (ApM3U/ApM3L), or
55,5 °C (ApM4U/ApM4L) for 1 min, and elongation at 72 °C for 2 min
in each cycle.
Expression plasmid for TTV-VP3
To supply TTV-VP3 in cells, pTTV-VP3 was constructed. A
complete open reading frame of the TTV-VP3 gene was ampliﬁed
by PCR using pBKVT416(1.3G)CMV(−) (GenBank AB041007) (Kama-
hora et al., 2000) as the template, and a pair of primers VP3-Not (5′-
TAG CGG CCG CC689T AGC AGG TCT GCG TCT TCG670-3′) and VP3-
KspI (5–AGC CGC GGT373 GAT CAA CAC TAC CTT AAC TGG394–3).
Each primer contained NotI or SacII (KspI) site, for cloning purpose
(indicated in italics). PCR was performed for 30 cycles with dena-
turing at 94 °C for 1 min, annealing at 55 °C for 1 min (for the ﬁrst
15 cycles) and at 60 °C for 1 min (for an additional 15 cycles), and
elongation at 72 °C for 1 min in each cycle. The PCR products di-
gested with SacII and NotI were inserted into SacII and NotI site of
pHM6, respectively.
Preparation of replicative form (RF) DNA
Each molecular clone of CAV in an amount of 5.0 μg was digested
with XbaI. After electrophoresis on a 1% agarose, viral DNA was
extracted by the gel extraction kit, and 200 ng of the DNA preparation
was circularized by the T4 DNA ligase. DNA was extracted with
phenol-chloroform (1:1) and precipitatedwith ethanol. The pellet was
washed with 70% ethanol, dried, and resolved in 10 μL of ﬁltered TE
buffer (10 mM Tris–HCl, pH 7.5, 1 mM EDTA).
DNA transfection
MDCC-MSB1 cells (1×106 cells/2 mL) in RPMI medium free from
antibiotics were delivered to the 6-well plate. The RF DNA (200 ng) in
10 μL was transfected with FuGENE HD (Roche Diagnostics) according
to manufacturer's instruction. For complementation experiments, the
RF DNA was co-transfected with 1.0 μg of a plasmid expressing
apoptin or its mutant protein. Every 24 h, cells were washed with
dication-free phosphate buffered saline [PBS(−)] for three times, and
resuspended with fresh complete RPMI medium to minimize the
amount of DNA contamination.
Harvest
The culture at 72 h posttransfection, unless otherwise stated,
was harvested for titration of infectious virus and DNA. The 2-mL
supernatant was used for extracellular virus and DNA prepara-
tion after centrifugation at 3000 g for 5 min and ﬁltration through
a 0.45 mm Sartorius membrane ﬁlter. The cells were washed twice
and resuspended in 2 mL of PBS(−). One-mL aliquot was cen-
trifuged and the cell pellet was used for DNA extraction. Another
aliquot was freeze-thawed three times, ﬁltered through the
membrane ﬁlter, and tested for infectious virus titer. Aliquots of
the infectious virus and DNA samples were freeze-stocked at
−20 °C.
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DNA was extracted using methods described previously (Laird
et al., 1991). Brieﬂy, 500 μL of lysis buffer (100 mM Tris–HCl, pH 8.5,
5 mM EDTA, 0.2% sodium dodecyl sulfate [SDS], 200 mM NaCl, 100 μg/
mL proteinase K) was added into the sample, and incubated at 37 °C
with agitation for 3 h. One volume of isopropanol (500 μL) was added
to the lysate and the samples were mixed until precipitation is
complete. The DNA precipitate was then recovered and dissolved in
100 μL of TE buffer. The concentration of DNA was measured using
NanoDrop (NanoDrop Technologies, San Diego, CA).
DNA preparation for digestion of prokaryotic DNA by Dpn I
Sample obtained either from culture ﬂuid or cell extract after
transfection was heavily contaminated with prokaryotic input DNA.
The maximum efﬁciency of the Dpn I digestion was approximately
99.9% (data not shown). To keep the undigested prokaryotic DNA
undetectable after Dpn I digestion, the DNA sample was ﬁrst titrated
by a seminested PCR (Kamada et al., 2006), and adjusted the DNA
concentration to b4×108 copies CAV DNA/mL. Thereafter, the sample
was digested with Dpn I at 37 °C for 16 h in NEBuffer 4 (New England
BioLabs).
Titration of CAV DNA
CAV-DNA was titrated semiquantitatively using serial ten-fold
dilutions and six tubes parallel in each dilution. Brieﬂy, DNA sample
(10 μL) was served for a single-step PCR using a pair of primers,
ABO3F2 (5′-A1585AA GGC GAA CAA CCG ATG A1603-3′) and CAVPU7
(5′-1746CCA CCA AGC TTG CGT GCT ATT C1725-3), and 1.25 U of BIOTAQ
polymerase (Bioline, London, UK) in 50-μL reaction volume. Follow-
ing an initial 3-min denaturation step at 94 °C, 30 cycles of PCR were
carried out comprising of 1 min at 94 °C, 1 min at 60 °C, and 2 min at
72 °C (10 min in the last cycle). After electrophoresis on a 3% agarose
gel, the gel was stained with ethidium bromide. The sensitivity of this
PCR assay was conﬁrmed as 104 copies per reaction by quantifying
pCAV/WT DNA as a template using the seminested PCR (Kamada
et al., 2006). Because of contamination of prokaryotic DNA even after
the optimized Dpn I digestion, this reduced sensitivity of the assay
was selected. The titer was calculated using the Behrens–Karber
method (Karber, 1931). Because the target region of this PCR is
indifferent from apoptin gene, co-transfection of the apoptin
expressing plasmid did not disturb the PCR. The experiments were
repeated at least three times, and each experiment resulted in
essentially the same results.
Titration of infectious CAV
CAV was titrated by a modiﬁcation of the microtest method
reported previously (Goryo et al., 1987). Serial ten-fold dilutions were
performed and 25 μL of each dilution was inoculated into each of six
wells containing 2×105 MDCC-MSB1 cells in 200 μL of the RPMI
complete medium. After two days, a quarter of cells was subcultured
in the complete medium. Two days after the subculture, cells were
harvested. DNA was extracted and dissolved in 100 μL of TE, and a 10-
μL aliquot of the DNA was used as template for the above-mentioned
single PCR. This assay system was conﬁrmed to have the same
sensitivity as the previously described microtest method by Goryo
et al. (1987), in which seven consecutive sub-cultures are required.
Similar titration system has been reported by van Santen et al. (2004).
Southern blot analysis
MDDC-MSB1 cells were transfected with RF DNA of various forms
of CAVs. The extracted DNA,10 μg in each lane, was electrophoresed on1% agarose gel, and blotted onto a Hybond-N+ ﬁlter (GE Healthcare,
NJ) as described by Southern (1975). After UV cross linking, the DNA
was prehybridized in DIG Easy Hyb solution (Roche) for 30 min at
49 °C and subsequently hybridized with DIG probe in the hybridiza-
tion solution for 18 h at 49 °C. The DIG probe consisting of the genomic
region used for PCR was generated using pCAV/WT as a template, and
ABO3F2 and CAVPU7 as primers by a PCR DIG Probe Synthesis Kit
(Roche). The blot was washed twice at the low-stringency condition
for 5 min at 25 °C with 2×SSC (300 mM NaCl, 30 mM sodium citrate,
pH 7.0) and 0.1% SDS, and twice at the high-stringency condition for
15 min at 68 °C with 0.1×SSC and 0.1% SDS. The DIG-labeled DNAwas
developed by a DIG Luminescent Detection Kit (Roche).
Puriﬁcation of virus particles
Virus particles were partially puriﬁed by the previously described
methodswithminormodiﬁcations (Todd et al., 1990). The cells (2×106
cells/5 mL) in RPMI medium free of antibiotics were delivered to a 6-
cm dish and transfected with 1 μg of RF DNA by FuGENE HD. For
complementation experiments, the RF DNA of CAV/mAp(−) (200 ng)
was co-transfected with 4.0 μg of pApWT or pTTV-VP3. After 72 h
posttransfection, cells were washed three times with PBS(−), and
resuspended in 1 mL of PBS(−). After three cycles of quick freezing-
thawing, samples were treated with 0.5% SDS for 30 min at 37 °C. Cell
debris was removed by centrifugation at 1.0×104 g for 30 min at 15 °C.
The supernatant was collected, and a 500-μL portion of it was layered
onto 10 mL of a continuous 30–60% sucrose gradient in TE, and
centrifuged at 8×104 g for 17 h at 15 °C using a Beckman SW41Ti rotor.
Fractions (1.5 mL each) were collected from the bottom. Parts of each
fraction served for determination of sucrose density with a refract-
ometer and for virus titration. Virus particles in each fraction were
pelleted by centrifugation at 2×105 g for 30 min at 17 °C using a
Beckman SW55Ti rotor, and resuspended in 125 μL of TE. The viral
DNA was titrated by PCR described above.
Immunoﬂuorescence
For analyzing the distribution of apoptin in cells, COS-1 cells were
selected. The localization of apoptin was hardly visualized in MDCC-
MSB1 cells, because transfection efﬁciency in MDCC-MSB1 cells was
very low and small ﬂoating MDCC-MSB1 cells do not have much
cytoplasmic area. One night prior to transfection, the cells were
delivered into 8-well chamber slides. Cells were transfected with 1 μg
of a expression plasmid with FuGENE HD, air-dried at 48 h
posttransfection, and ﬁxed with 4% paraformaldehyde in PBS(−) for
10 min at room temperature. After consecutive washings with PBS(−)
and 0.1% Triton X-100 in PBS(−), the slides were blocked with 15 μL/
well of 1.5% normal sheep serum in PBS(−) at 37 °C for 30min. The cells
were incubated with 1/100 dilution of anti-HA high-afﬁnity rat
monoclonal antibody (Roche Diagnostics), and thenwith 1/1000 Alexa
Fluor 594 goat anti-rat IgG antibody (Invitrogen, Carlsbad, CA), each
for 60 min at room temperature. The slides were mounted with 5 ng
(5 μL)/well of Vectorshield with 4′-6-diamidino-2′-phenylindole
dihydrochloride (DAPI, Vector Laboratories, Burligame, CA), and
observed under a inverted ﬂuorescent microscope (BX60: Olympus,
Tokyo, Japan). The specimen was thoroughly washed with PBS(−)
between each step unless otherwise stated.
To analyze the nuclear and cytoplasmic localization of apoptin and
TTV VP3, three different methods were used because of the subjective
nature of the analysis. First, cells double stained with anti-HA
antibody and DAPI were examined manually under ﬂuorescent
microscope: cells with pink nuclei were scored as the nuclear staining.
Second, double stained cells were scanned by “ﬁnd edges function” of
ImageJ, a public domain image analysis software (Abramoff, Magel-
haes, and Ram, 2004). To eliminate background signals, the threshold
range of apoptin color signal was determined using typical cells
92 A.A. Prasetyo et al. / Virology 385 (2009) 85–92stained for apoptin. Cells with N50% signal in nuclear region were
scored as cells with the nuclear staining. Finally, merged imagewas re-
processed using macro command written by Carmona et al. (2007).
The results with these three different methods were almost identical
(proportion of cells with dominant nuclear staining: ApWT, 60–75%;
ApT108I, 30–45%; Ap1, 80–95%; Ap2, 80–95%; Ap3, 5–30%; Ap4, 5–20%;
TTV-VP3, 60–70%).
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